[1] |
LI Yanyang, WANG Yunjiao, LV Shichao.
Effects and mechanism of traditional Chinese medicine injection in prevention and treatment of cardiotoxicity induced by antineoplastic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 572-577.
|
[2] |
CAO Xuefen, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, LYU Xingjiao, Janvier NIBARUTA.
Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1201-1208.
|
[3] |
WANG Xinli, XU Xiaqing, FANG Hanbing, GUO Yuzhong.
Study of TPA on enhancing the anti-tumor effects of cisplatin and reducing its renal toxicity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 535-543.
|
[4] |
FAN Di, SHI Cuina, YANG Qingqing, JI Muhuo.
Research progress on effects of sevoflurane anesthesia on developing brain
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1333-1339.
|
[5] |
YAO Yiting, LIU Hanyu, WU Zifeng, WANG Di, YANG Chun, HUANG Chaoli.
Research progresses in toxic effects and mechanism of anesthetics on the developing nervous system
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1354-1364.
|
[6] |
YANG Liu, LUO Ailin, LI Shiyong.
Advance of general anesthetics-induced developing brain injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1381-1390.
|
[7] |
CHEN Sen, FAN Chang, ZHANG Jiafu, MA Yanzhen, JIANG Hui.
The mechanism of Shugan Jianpi Formula regulating TLR4/MyD88/NLRP3 signaling axis to inhibit pyroptosis in mice with liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1081-1089.
|
[8] |
LIU Wenjing, WU Zhitao, PAN Guoyu.
Early dectection and prediction hepatotoxic risk in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 923-930.
|
[9] |
DING Xueming, CHEN Tianpeng, XU Qiang, HE Huan, HE Ming.
Tetramethylpyrazine attenuates doxorubicin induced cardiotoxicity through 14-3-3γ/Bcl-2
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 361-367.
|
[10] |
ZHAO Fangqing, YANG Wenwen, YIN Yujie, ZHANG Bin, WANG Bangcai, DOU Xiaobing, LI Songtao, ZHU Linwensi.
Salvianolic acid A activates AMPK and SIRT1 to reduce palmitic acid-induced lipotoxicity in hepatocyte
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 241-249.
|
[11] |
XU Tiantian, WU Xiangyao, PI Aiwen, CHAI Hui, ZHANG Bin, WANG Bangcai, DOU Xiaobing, ZHU Linwensi.
Salvianolic acid A improves palmitie acid-induced lipotoxicity in cardiomyocyte via inhibiting TLR4/JNK MAPK
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 121-128.
|
[12] |
FU Ai, XU Tiantian, YANG Zhen, HAN Qiang, DOU Xiaobing, LI Songtao.
Ferulic acid protects palmitic acid-induced lipotoxicity in hepatocytes via inhibiting p38 MAPK
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 137-143.
|
[13] |
DENG Li, TIAN Jing.
Resveratrol suppresses NLRP3 inflammasome activation in colonic epithelial cells triggered by Escherichia coli O104∶H4
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 167-173.
|
[14] |
ZHANG Pinghu, ZHANG Ling, LIU Changxiao.
Research progress of mitochondrial toxicity evaluation model for nucleoside drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1059-1065.
|
[15] |
JIANG Weiyu, HU Xudong, CHEN Yunlin, RUAN Chaoyue, XU Nanjian, WANG Yang, XU Dingli, ZHANG Jiaming, LI Haojie, MA Weihu.
Esveratrol inhibits NLRP3 inflammasome activation in rabbits with spinal cord injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 850-856.
|